Differential Vitreous Dye Diffusion Following Microplasmin or Plasmin Pre-Treatment

REFERENCES

• Sebag J. Anomalous posterior vitreous detachment: A unifying concept in vitreo-retinal disease. Graefe’s Arch Clin Exp Ophthalmol 2004;242:690–698.
   PubMed Web of Science ®Google Scholar
• Akiba J, Arzabe CW, Trempe CL. Posterior vitreous detachment and neovascularization in diabetic retinopathy. Ophthalmol 1990;97:889–891.
   PubMed Web of Science ®Google Scholar
• Akiba J, Quiroz MA, Trempe CL. Role of posterior vitreous detachment in idiopathic macular holes. Ophthalmol 1990;97:1610–1613.
   PubMed Web of Science ®Google Scholar
• Chu TG, lopez PF, Cano MR, et al. Posterior vitreoschisis. An echographic finding in proliferative diabetic retinopathy. Ophthalmol 1996;103:315–322.
   PubMed Web of Science ®Google Scholar
• Sarrafizadeh R, Hassan TS, Ruby AJ, et al. Incidence of retinal detachment and visual outcome in eyes presenting with posterior vitreous separation and dense fundus-obscuring vitreous hemorrhage. Ophthalmol 2001;108:2273–2278.
   PubMed Web of Science ®Google Scholar
• Sebag J. Anatomy and pathology of the vitreoretinal interface. Eye 1992;6:541–552.
   PubMed Web of Science ®Google Scholar
• Sebag J. Is pharmacologic vitreolysis brewing? Retina 2002;22:1–3.
   PubMed Web of Science ®Google Scholar
• Kuppermann BD, Thomas EL, de Smet MD, et al. The Vitrase for Vitreous Hemorrhage Study Groups. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 2005;140:573–584.
   PubMed Web of Science ®Google Scholar
• Oliveira LB, Tatebayashi M, Mahmoud TH, et al. Dispase facilitates posterior vitreous detachment during vitrectomy in young pigs. Retina 2001;21:342–331.
   Google Scholar
• Staubach F, Nober V, Janknecht P. Enzyme-assisted vitrectomy in enucleated pig eyes: A comparison of hyaluronidase, chondroitinase, and plasmin. Curr Eye Res 2004;29:261–268.
   PubMed Web of Science ®Google Scholar
• Tripathi RC, Tripathi BJ, Park JK, et al. Intracameral tissue plasminogen activator for resolution of fibrin clots after glaucoma filtering procedures. Am J Ophthalmol 1991;111:247–248.
   PubMed Web of Science ®Google Scholar
• Wang F, Wang Z, Sun X, et al. Safety and efficacy of dispase and plasmin in pharmacologic vitreolysis. Invest Ophthalmol Vis Sci 2004;45:3296–3290.
   Google Scholar
• Pluen A, Netti PA, Jain RK, et al. Diffusion of macromolecules in agarose gels: Comparison of linear and globular configurations. Biophys J 1999;77:542–562.
   PubMed Web of Science ®Google Scholar
• Johnson EM, Berk DA, Jain RK, et al. Hindered diffusion in agarose gels: Test of effective medium model. Biophys J 1996;70:1017–1026.
   PubMed Web of Science ®Google Scholar
• Kim H, Robinson SM, Csaky KG. Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina. Pharmaceutical Research. 2009;26:329–337.
   PubMed Web of Science ®Google Scholar
• Castellino FJ, Ploplis VA.Human plasminogen: Structure, activation, and function. In: DM Waisman (Ed.). Plasminogen: Structure, Activation, and Regulation. Dordrecht, Netherlands: Kluwer Academic/Plenum Publishers, 2003; pp. 3–17.
   Google Scholar
• Ma Z, Lu W, Wu S, et al. Expression and characterization of recombinant human micro-plasminogen. Biotechnol Lett 2007;29:517–523.
   Google Scholar
• Nagai N, Demarsin E, Van Hoef B, et al. Recombinant human microplasmin: Production and potential therapeutic properties. J Thrombosis & Haemostasis 2003;1:307–313.
   PubMed Web of Science ®Google Scholar
• Shi GY, Wu HL. Isolation and characterization of microplasminogen: A low molecular weight form of plasminogen. J Biol Chem 1988;263:17071–17075.
   PubMed Web of Science ®Google Scholar
• de Smet MD, Gandorfer A, Stalmans P, et al. Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: The MIVI I trial. Ophthalmol 2009;116:1349–1355.
   PubMed Web of Science ®Google Scholar
• de Smet MD, Valmaggia C, Zarrantz J, et al. Microplasmin: Ex vivo characterization of its activity in porcine vitreous. Invest Ophthalmol Vis Sci 2009;50:814–819.
   PubMed Web of Science ®Google Scholar
• Bhisitkul RB. Anticipation for enzymatic vitreolysis. Br J Ophthalmol 2001;85:1–3.
   PubMed Web of Science ®Google Scholar
• Trese MT. Enzymatic vitreous surgery. Semin Ophthalmol 2000;15:116–121.
   PubMedGoogle Scholar
• Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmol 2000;107:1607–1611.
   PubMed Web of Science ®Google Scholar
• Stefánsson E. Physiology of vitreous surgery. Graefe’s Arch Clin Experimental Ophthalmol 2009;247:147–163.
   PubMed Web of Science ®Google Scholar
• Tojo K. A pharmacokinetic model for ocular drug delivery. Chem & Pharmaceut Bull 2004;52:1290–1294.
   PubMed Web of Science ®Google Scholar
• Tojo K, Isowaki A. Pharmacokinetic model for in vivo/in vitro correlation of intravitreal drug delivery. Adv Drug Deliv Rev 2001;52:17–24.
   PubMedGoogle Scholar
• Verstraeten TC, Chapman C, Hartzer M, et al. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol 1993;111:849–854.
   PubMedGoogle Scholar
• Sebag J, Ansari R, Suh K. Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients. Graefe’s Arch Clin and Experimental Ophthalmol 2007;245:576–580.
   PubMed Web of Science ®Google Scholar
• Mukai, N, Nakanishi T, Shimizu A, et al. Identification of phosphotyrosyl proteins in vitreous humours of patients with vitreoretinal diseases by sodium dodecyl sulphate-polyacrylamide gel electrophoresis/Western blotting/matrix-assisted laser desorption time-of-flight mass spectrometry. Ann Clin Biochem 2008;45:307–312.
   Google Scholar